Calzada has 100% ownership of PolyNovo Biomaterials Pty Ltd and Metabolic Pharmaceuticals Pty Ltd. The company is listed on the Australian Securities Exchange (ASX Code CZD). Read More
> PolyNovo Commences Second Human Trial > PolyNovo Human Trial Update > AOD9604 Positive in Cartilage and Muscle Repair > Metabolic Commences Seeking Partners for Bone Applications
